Palle J, Hirsch L, Lapeyre-Prost A, Malka D, Bourhis M, Pernot S, Marcheteau E, Voron T, Castan F, Lacotte A, et al
They offer a systemic approach, meaning they address symptoms throughout the body
Quick answer: BPC-157 and thymosin beta-4 fragment (TB-500) are two short peptides that show up together a lot in preclinical tissue-repair literature, which is why several research vendors supply them as a co-formulated vial
When considering the use of viral vectors in NDDs, some important considerations include balancing tissue-specificity, immunogenicity, packaging limits, and ability to penetrate the BBB
86 Blocking the effects of GH in patients with acromegaly improves diabetes and glucose metabolism